MS

Manjit Singh Sawhney

Director Director DIN 02628319
DIN 02628319 First appointment Apr 1995 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 1995
Shareholding value •••• Premium profile

About Manjit Singh Sawhney

Data last updated:

Manjit Singh Sawhney was a Director at Alpha Remedies Limited (1995–2018) and Partner at Spring Ivy Educational Services Llp (2015–2020). The companies operate in Pharma and Education & Learing.

DIN 02628319
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 1995

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alpha Remedies Limited U24208MH1988PLC046746
Director01 Apr 19951988₹4,000 (FY 2025)Active
Partner10 Feb 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alpha Remedies Limited
Spring Ivy Educational Services Llp
Premium access

Shareholding and investment profile for Manjit Singh Sawhney

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjit Singh Sawhney

Manjit Singh Sawhney was first appointed on 01 Apr 1995 as Director at Alpha Remedies Limited. The most recent appointment on record is 10 Feb 2015 at Spring Ivy Educational Services Llp.

Manjit Singh Sawhney held 2 earlier board appointments: Alpha Remedies Limited (Director, 01 Apr 1995 to 19 Mar 2018); Spring Ivy Educational Services Llp (Partner, 10 Feb 2015 to 30 Nov 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available